Transgene Announces Upcoming Investor Meetings

information fournie par Boursorama •03/09/2018 à 18:00

Transgene Announces Upcoming Investor Meetings


Strasbourg, France, September 3, 2018, 6:00 pm CET – Transgene (Euronext Paris : TNG) today announces that management will participate in the upcoming investor events set out below.

• H. C. Wainwright Annual Global Investment Conference (Rodman & Renshaw): September 5 & 6, 2018 – New York, USA
• Séminaire Biotech Portzamparc: September 5, 2018 – Paris, France
• Large & Midcap Event: October 8 & 9, 2018 – Paris, France
• Actionaria: November 22 & 23, 2018 – Paris, France
• Bryan Garnier, Annual Healthcare Conference: November 23, 2018 – Paris, France
• Eigenkapital Forum: November 26 & 27, 2018 – Frankfurt, Germany
• Geneva MidCap Event: December 4 & 5, 2018 – Geneva, Switzerland

Next scheduled financial communication
First Half 2018 Financial Results
September 19, 2018, after close of market

Contacts

Transgene:
Lucie Larguier
Director Corporate Communications & IR
+33 (0)3 88 27 91 04
investorrelations@transgene.fr
Media contacts:

Citigate Dewe Rogerson
David Dible / Marine Perrier
+ 44 (0)20 7638 9571
transgene@citigatedewerogerson.com